Correlation Between Eisai and THC Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eisai and THC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eisai and THC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eisai Co and THC Therapeutics, you can compare the effects of market volatilities on Eisai and THC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eisai with a short position of THC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eisai and THC Therapeutics.

Diversification Opportunities for Eisai and THC Therapeutics

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Eisai and THC is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Eisai Co and THC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on THC Therapeutics and Eisai is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eisai Co are associated (or correlated) with THC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of THC Therapeutics has no effect on the direction of Eisai i.e., Eisai and THC Therapeutics go up and down completely randomly.

Pair Corralation between Eisai and THC Therapeutics

Assuming the 90 days horizon Eisai Co is expected to under-perform the THC Therapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, Eisai Co is 81.94 times less risky than THC Therapeutics. The pink sheet trades about -0.26 of its potential returns per unit of risk. The THC Therapeutics is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  0.04  in THC Therapeutics on August 25, 2024 and sell it today you would earn a total of  0.42  from holding THC Therapeutics or generate 1050.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Eisai Co  vs.  THC Therapeutics

 Performance 
       Timeline  
Eisai 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eisai Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
THC Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in THC Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively abnormal fundamental indicators, THC Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Eisai and THC Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eisai and THC Therapeutics

The main advantage of trading using opposite Eisai and THC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eisai position performs unexpectedly, THC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in THC Therapeutics will offset losses from the drop in THC Therapeutics' long position.
The idea behind Eisai Co and THC Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets